[1] BRAY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
[2] FREIMAN M R,CLARK J A,SLATORE C G,et al.Patients'knowledge,beliefs,and distress associated with detection and evaluation of incidental pulmonary nodules for cancer:results from a multicenter survey[J].Journal of Thoracic Oncology,2016,11(5):700-708.
[3] TRESKOVA M,AUMANN I,GOLPON H,et al.Trade-off between benefits,harms and economic efficiency of low-dose CT lung cancer screening:a microsimulation analysis of nodule management strategies in a population-based setting[J].BMC Medicine,2017,15(1):162-178..
[4] 王璐,洪群英.肺结节诊治中国专家共识(2018年版)解读[J].中国实用内科杂志,2019,39(5):440-442.
[5] BALDWIN D R,CALLISTER M E.The British Thoracic Society guidelines on the investigation and management of pulmonary nodules[J].Thorax,2015,70(8):794-798.
[6] BALDWIN D R,CALLISTER M E J,GRAHAM R,et al.Pulmonary nodules again?The 2015 British Thoracic Society guidelines on the investigation and management of pulmonary nodules[J].Clinical Radiology,2016,71(1):18-22.
[7] HEBER MACMAHON M B,DAVID P,NAIDICH M,et al.guidelines for management of incidental pulmonary nodules detected on CT images:from the Fleischner Society 2017[J].Radiology,2017,284(1):228-243.
[8] GOULD M K,TANG T,LIU I A,et al.Recent trends in the identification of incidental pulmonary nodules[J].American Journal of Respiratory and Critical Care Medicine,2015,192(10):1208-1214.
[9] MARRERÉ,JOLLY D,ARVEUX P,et al.Incidence of solitary pulmonary nodules in Northeastern France:a population-based study in five regions[J].BMC Cancer,2017,17(1):47.
[10] 赵俊松,崔利,何江波,等.上海22 351例无症状体检者低剂量CT肺癌筛查及随访结果初步分析[J].诊断学理论与实践,2019,18(2):183-188.
[11] 刘玉萍,冯刚.体检人群低剂量CT早期肺癌筛查结果及危险因素分析[J].中华老年医学杂志,2017,36(11):1242-1246.
[12] WALTER J E,HEUVELMANS M A,OUDKERK M.Small pulmonary nodules in baseline and incidence screening rounds of low-dose CT lung cancer screening[J].Transl Lung Cancer Res,2017,6(1):42-51.
[13] FIELD J K,DUFFY S W,BALDWIN D R,et al.UK Lung Cancer RCT Pilot Screening Trial:baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening[J].Thorax,2016,71(2):161-170.
[14] TEAM N L S T.Reduced lung-cancer mortality with low-dose computed tomographic screening[J].New England Journal of Medicine,2011,365(5):395-409.
[15] HEUVELMANS M A,WALTER J E,PETERS R B,et al.Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening:the NELSON study[J].Lung Cancer,2017,113:45-50.
[16] WALTER J E,HEUVELMANS M A,DE BOCK G H,et al.Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening:the NELSON study[J].Lung Cancer,2018,125:103-108.
[17] HU X,ZHAO J,QIAN H,et al.Radiological and pathological analysis of LDCT screen detected and surgically resected sub-centimetre lung nodules in 44 asymptomatic patients[J].European Journal of Radiology Open,2016,3:223-229.
[18] HOREWEG N,VAN ROSMALEN J,HEUVELMANS M A,et al.Lung cancer probability in patients with CT-detected pulmonary nodules:a prespecifi ed analysis of data from the NELSON trial of low-dose CT screening[J].Lancet Oncology,2014,15(12):1332-1341.
[19] MCWILLIAMS A,TAMMEMAGI M C,MAYO J R,et al.Probability of cancer in pulmonary nodules detected on first screening CT[J].New England Journal of Medicine,2013,369(10):910-919.
[20] FAN L,WANG Y,ZHOU Y,et al.Lung cancer screening with low-dose CT:baseline screening results in Shanghai[J].Academic radiology,2019,26(10):1283-1291.
[21] WU G X,RAZ D J,BROWN L,et al.Psychological burden associated with lung cancer screening:a systematic review[J].Clinical Lung Cancer,2016,17(5):315-324.
[22] WOOD D E,KAZEROONI E A,BAUM S L,et al.Lung cancer screening,Version 3.2018,NCCN Clinical Practice Guidelines in Oncology[J].Journal of the National Comprehensive Cancer Network,2018,16(4):412-441.
[23] SULLIVAN D R,GOLDEN S E,GANZINI L,et al.'I still don't know diddly':a longitudinal qualitative study of patients'knowledge and distress while undergoing evaluation of incidental pulmonary nodules[J].NPJ Primary Care Respiratory Medicine,2015,25(1):15028.
[24] MOSESON E M,WIENER R S,GOLDEN S E,et al.Patient and clinician characteristics associated with adherence[J].Annals of the American Thoracic Society,2016,13(5):651-659.
[25] SLATORE C G,WIENER R S.Pulmonary Nodules[J].Chest,2018,153(4):1004-1015.
[26] VAN DEN BERGH K A M,ESSINK-BOT M L,BORSBOOM G J J M,et al.Long-term effects of lung cancer computed tomography screening on health-related quality of life:the NELSON trial[J].European Respiratory Journal,2011,38(1):154-161.
[27] WIENER R S,GOULD M K,WOLOSHIN S,et al.'The thing is not knowing':patients'perspectives on surveillance of an indeterminate pulmonary nodule[J].Health Expectations, 2015,18(3):355-365.
[28] SLATORE C G,PRESS N,AU D H,et al.What the heck is a "nodule"?A qualitative study of veterans with pulmonary nodules[J].Annals of the American Thoracic Society,2013,10(4):330-335.
[29] SLATORE C G,WIENER R S,GOLDEN S E,et al.Longitudinal assessment of distress among veterans with incidental pulmonary nodules[J].Ann Am Thorac Soc,2016,13(11):1983-1991.
[30] WIENER R S.Opening the black box of communication and decision-making for lung cancer screening and nodule evaluation.implications for policy and practice[J].Annals of the American Thoracic Society,2016,13(11):1887-1889.
[31] KOROSCIL M T,BOWMAN M H,MORRIS M J,et al.Effect of a pulmonary nodule fact sheet on patient anxiety and knowledge:a quality improvement initiative[J].BMJ Open Quality,2018,7(3):e437.
[32] TEAM T N L S.Reduced lung-cancer mortality with low-dose computed reduced lung-cancer mortality with low-dose computed tomographic screening[J].The New England Journal of Medicine,2011,365(5):395-409.
[33] SHANKAR A,SAINI D,DUBEY A,et al.Feasibility of lung cancer screening in developing countries:challenges,opportunities and way forward[J].Translational Lung Cancer Research,2019,8(S1):S106-S121.
[34] SLATORE C G,SULLIVAN D R,PAPPAS M,et al.Patient-centered outcomes among lung cancer screening recipients with computed tomography:a systematic review[J].Journal of Thoracic Oncology,2014,9(7):927-934.
[35] SCHAPIRA M M,AGGARWAL C,AKERS S,et al.How patients view lung cancer screening the role of uncertainty in medical decision making[J].Annals of the American Thoracic Society,2016,13(11):1969-1976.
[36] KANG H,CHEN V C,HUNG W,et al.Preliminary comparison of neuropsychological performance in patients with non-small-cell lung cancer treated with chemotherapy or targeted therapy[J].Neuropsychiatric Disease and Treatment,2019,15(1):753-761.
[37] KOTOV R,GAMEZ W,SCHMIDT F,et al.Linking "big" personality traits to anxiety,depressive,and substance use disorders:a meta-analysis[J].Psychological Bulletin,2010,136(5):768-821.
[38] BRANDES M,BIENVENU O J.Personality and anxiety disorders[J].Current Psychiatry Reports,2006,8(1):263-269. |
